
Sign up to save your podcasts
Or


Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:
By Sequoia Capital4.2
3636 ratings
Patrick Hsu, co-founder of Arc Institute, discusses the opportunities for AI in biology beyond just drug development, and how Evo 2, their new biology foundation model, is enabling a broad ecosystem of applications. Evo 2 was trained on a vast dataset of genomic data to learn evolutionary patterns that would have taken years to find; as a result, the model can be used for applications from identifying mutations that cause disease to designing new molecular and even genome scale biological systems.
Hosted by Josephine Chen and Pat Grady, Sequoia Capital
Mentioned in this episode:

1,285 Listeners

531 Listeners

1,095 Listeners

228 Listeners

204 Listeners

96 Listeners

192 Listeners

516 Listeners

130 Listeners

91 Listeners

98 Listeners

473 Listeners

36 Listeners

22 Listeners

43 Listeners

36 Listeners